Please try another search
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Name | Age | Since | Title |
---|---|---|---|
Koen Hoffman | 54 | 2018 | Independent Non-Executive Chairman |
Michael K. McGarrity | 59 | 2019 | CEO & Executive Director |
Regine Slagmulder | 55 | 2020 | Independent Non-Executive Director |
Gerrit A. Meijer | - | - | Member of Scientific Advisory Board |
Jonathan I. Epstein | - | 2011 | Member of Scientific Advisory Board |
James G. Herman | - | - | Member of Scientific Advisory Board |
Jan Groen | 62 | 2010 | Advisor to the Board |
Donnie M. Hardison | 71 | 2021 | Independent Non-Executive Director |
Eric M. Wallen | - | 2011 | Member of Scientific Advisory Board |
Hilde Windels | 57 | 2017 | Independent Non-Executive Director |
Godelieve Verplancke | 64 | 2017 | Independent Non-Executive Director |
Eric Bednarski | - | 2020 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review